Tim Trost
About Tim Trost
Tim Trost Professional Background
Tim Trost has held several prominent financial positions across various companies. He served as Chief Financial Officer at Asklepios Biopharmaceutical, Inc. from May 2020 until its acquisition by Bayer AG in December 2020. Before this, he worked as Senior Vice President and Chief Financial Officer at Chimerix, Inc. from March 2011 to May 2019. Additionally, he held the roles of Vice President and Chief Financial Officer at Argos Therapeutics, Inc., and Senior Vice President and Chief Financial Officer at InteCardia, Inc., which Syncor International Corporation acquired. He also served as Executive Vice President and Chief Financial Officer of Coastal Physician Group, Inc.
Tim Trost Professional Expertise
Tim Trost has extensive expertise in financial management, particularly within the biopharmaceutical and healthcare sectors. His roles as Chief Financial Officer at multiple organizations have equipped him with in-depth knowledge in financial strategy, corporate finance, and mergers and acquisitions. His tenure at InteCardia, Inc., which was acquired by Syncor International Corporation, and at Asklepios Biopharmaceutical, Inc., which Bayer AG acquired, highlight his experience in navigating corporate acquisitions and integrations.
Tim Trost Education
Tim Trost earned a Bachelor of Science degree in accounting from the University of Illinois at Urbana-Champaign. This educational background laid a strong foundation for his career in finance, equipping him with the necessary skills in accounting and financial analysis. Additionally, he is a Certified Public Accountant, further validating his expertise and professional qualification in financial management and accounting.
Tim Trost Early Career
Tim Trost began his career at PricewaterhouseCoopers LLP, where he last served as a Senior Manager in the Research Triangle practice. This role provided him with significant experience in auditing and financial consulting, setting the stage for his subsequent executive roles in various organizations. His time at PricewaterhouseCoopers allowed him to develop a keen understanding of financial operations and compliance, valuable assets in his later roles as Chief Financial Officer.